Skip to main content

Table 5 Treatment comparisons for TNSS from the diary cards: Period means over five days.

From: Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitis

Variable

Treatment

Mean differencea

95% CI

P-value

TNSS

-morning

AZD3778 vs. placebo

-0.459

-0.85, -0.067

0.023

 

Loratadine vs. placebo

-0.174

-0.569, 0.22

0.381

 

AZD3778 vs. loratadine

-0.285

-0.685, 0.115

0.159

TNSS

-evening

AZD3778 vs. placebo

-0.562

-1.04, -0.083

0.022

 

Loratadine vs. placebo

-0.172

-0.649, 0.305

0.474

 

AZD3778 vs. loratadine

-0.39

-0.868, 0.088

0.108

  1. AZD3778 reduced TNSS in the morning as well as in the evening.
  2. aAdjusted mean difference from ANOVA.